abstract |
The present invention relates to humanized affinity matured anti-FcRn antibodies. Provided herein are recombinant antibodies and antigen-binding portions thereof that can be used to bind to FcRn and block the binding of FcRn to IgG Fc. FcRn binding proteins can be used to treat a variety of disorders, including autoimmune disorders. |